| Product Code: ETC7743259 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Narcotic Drugs Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Narcotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Narcotic Drugs Market - Industry Life Cycle |
3.4 Japan Narcotic Drugs Market - Porter's Five Forces |
3.5 Japan Narcotic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Japan Narcotic Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Japan Narcotic Drugs Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Japan Narcotic Drugs Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.9 Japan Narcotic Drugs Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Japan Narcotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring pain management, leading to higher demand for narcotic drugs. |
4.2.2 Growing aging population in Japan, which is more prone to chronic pain conditions. |
4.2.3 Rising government initiatives to improve access to palliative care and pain management services. |
4.3 Market Restraints |
4.3.1 Stringent regulatory environment surrounding the use and distribution of narcotic drugs in Japan. |
4.3.2 Concerns over misuse, abuse, and addiction to narcotic drugs leading to stricter monitoring and control measures. |
4.3.3 Limited public awareness and stigma associated with opioid use for pain management. |
5 Japan Narcotic Drugs Market Trends |
6 Japan Narcotic Drugs Market, By Types |
6.1 Japan Narcotic Drugs Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Japan Narcotic Drugs Market Revenues & Volume, By Source, 2021- 2031F |
6.1.3 Japan Narcotic Drugs Market Revenues & Volume, By Natural, 2021- 2031F |
6.1.4 Japan Narcotic Drugs Market Revenues & Volume, By Semi-synthetic, 2021- 2031F |
6.1.5 Japan Narcotic Drugs Market Revenues & Volume, By Synthetic, 2021- 2031F |
6.2 Japan Narcotic Drugs Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Japan Narcotic Drugs Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.3 Japan Narcotic Drugs Market Revenues & Volume, By Cough, 2021- 2031F |
6.2.4 Japan Narcotic Drugs Market Revenues & Volume, By Diarrhea, 2021- 2031F |
6.2.5 Japan Narcotic Drugs Market Revenues & Volume, By Dysentery, 2021- 2031F |
6.2.6 Japan Narcotic Drugs Market Revenues & Volume, By Asthma, 2021- 2031F |
6.2.7 Japan Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan Narcotic Drugs Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 Japan Narcotic Drugs Market Revenues & Volume, By Opium, 2021- 2031F |
6.3.3 Japan Narcotic Drugs Market Revenues & Volume, By Heroin, 2021- 2031F |
6.3.4 Japan Narcotic Drugs Market Revenues & Volume, By Codeine, 2021- 2031F |
6.3.5 Japan Narcotic Drugs Market Revenues & Volume, By Oxycodone, 2021- 2031F |
6.3.6 Japan Narcotic Drugs Market Revenues & Volume, By Hydrocodone, 2021- 2031F |
6.3.7 Japan Narcotic Drugs Market Revenues & Volume, By Tramadol, 2021- 2031F |
6.3.8 Japan Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.9 Japan Narcotic Drugs Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.3.10 Japan Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Narcotic Drugs Market, By Administration |
6.4.1 Overview and Analysis |
6.4.2 Japan Narcotic Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Japan Narcotic Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Japan Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan Narcotic Drugs Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Japan Narcotic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Japan Narcotic Drugs Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Japan Narcotic Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Japan Narcotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Japan Narcotic Drugs Market Import-Export Trade Statistics |
7.1 Japan Narcotic Drugs Market Export to Major Countries |
7.2 Japan Narcotic Drugs Market Imports from Major Countries |
8 Japan Narcotic Drugs Market Key Performance Indicators |
8.1 Number of licensed healthcare providers specializing in pain management in Japan. |
8.2 Percentage of healthcare facilities equipped with proper infrastructure for safe administration of narcotic drugs. |
8.3 Patient satisfaction scores related to pain management services provided using narcotic drugs. |
9 Japan Narcotic Drugs Market - Opportunity Assessment |
9.1 Japan Narcotic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Japan Narcotic Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Japan Narcotic Drugs Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 Japan Narcotic Drugs Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.5 Japan Narcotic Drugs Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Japan Narcotic Drugs Market - Competitive Landscape |
10.1 Japan Narcotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Japan Narcotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here